Liat Vidal

Summary

Publications

  1. doi request reprint Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
    Liat Vidal
    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Cochrane Database Syst Rev 9:CD009045. 2012
  2. doi request reprint Immunotherapy for patients with follicular lymphoma: the contribution of systematic reviews
    Liat Vidal
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Tel Aviv University, Israel
    Acta Haematol 125:23-31. 2011
  3. ncbi request reprint Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
    Liat Vidal
    Department of Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel
    J Antimicrob Chemother 60:247-57. 2007
  4. doi request reprint Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials
    Liat Vidal
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva 49100, Israel
    J Natl Cancer Inst 103:1799-806. 2011
  5. doi request reprint Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials
    Liat Vidal
    Institute of Hematology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    J Natl Cancer Inst 101:248-55. 2009
  6. doi request reprint Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Int J Antimicrob Agents 40:123-6. 2012
  7. doi request reprint Toxicity of autologous hematopoietic cell transplantation in patients with multiple myeloma - comparison between two different induction regimens
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Clin Transplant 26:E549-54. 2012
  8. pmc Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis
    Ronit Gurion
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Israel
    Haematologica 98:95-102. 2013
  9. doi request reprint Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Am J Hematol 87:472-8. 2012
  10. doi request reprint Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia
    Ronit Gurion
    Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Cochrane Database Syst Rev 6:CD008238. 2012

Collaborators

Detail Information

Publications32

  1. doi request reprint Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
    Liat Vidal
    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Cochrane Database Syst Rev 9:CD009045. 2012
    ..A number of randomised controlled trials have examined the effect of bendamustine compared to other chemotherapy regimens in these patients. Improved disease control with no survival benefit is shown...
  2. doi request reprint Immunotherapy for patients with follicular lymphoma: the contribution of systematic reviews
    Liat Vidal
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Tel Aviv University, Israel
    Acta Haematol 125:23-31. 2011
    ..Eleven of them were eligible for this review and are described herein. These systematic reviews have dramatically influenced the approach to patients with follicular lymphoma...
  3. ncbi request reprint Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
    Liat Vidal
    Department of Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel
    J Antimicrob Chemother 60:247-57. 2007
    ..This study sought to compare the efficacy and adverse effects of any aminoglycoside as a single antibiotic with other antibiotics for the treatment of patients with infection...
  4. doi request reprint Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials
    Liat Vidal
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva 49100, Israel
    J Natl Cancer Inst 103:1799-806. 2011
    ..67, 95% CI = 1.40 to 2.00). These results further support the use of rituximab maintenance in the standard of care for refractory or relapsed follicular lymphoma...
  5. doi request reprint Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials
    Liat Vidal
    Institute of Hematology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    J Natl Cancer Inst 101:248-55. 2009
    ..We aimed to evaluate the effect of maintenance treatment with rituximab on the overall survival of patients with follicular lymphoma...
  6. doi request reprint Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Int J Antimicrob Agents 40:123-6. 2012
    ..Treatment guidelines should address the antibiotic treatment of breakthrough fever...
  7. doi request reprint Toxicity of autologous hematopoietic cell transplantation in patients with multiple myeloma - comparison between two different induction regimens
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Clin Transplant 26:E549-54. 2012
    ....
  8. pmc Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis
    Ronit Gurion
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Israel
    Haematologica 98:95-102. 2013
    ..Although an advantage is suggested by surrogate parameters, longer follow up is necessary to see if this translates into superior overall survival...
  9. doi request reprint Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Am J Hematol 87:472-8. 2012
    ..53, 95% CI 0.19-1.48). Pediatric-inspired regimens are superior to conventional-adult chemotherapy in AYA ALL patients. Further randomized controlled studies to investigate this approach in adult ALL patients are warranted...
  10. doi request reprint Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia
    Ronit Gurion
    Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Cochrane Database Syst Rev 6:CD008238. 2012
    ..However, their safety with regard to disease-related outcomes and survival in AML is unclear. Therefore, we performed a systematic review and meta-analysis to evaluate the impact of CSFs on patient outcomes, including survival...
  11. doi request reprint Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
    Anat Gafter-Gvili
    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski Street, PetahTikva, 49100, Israel
    Cochrane Database Syst Rev 1:CD004386. 2012
    ..Trials have shown the efficacy of antibiotic prophylaxis in reducing the incidence of bacterial infections but not in reducing mortality rates. Our systematic review from 2006 also showed a reduction in mortality...
  12. ncbi request reprint Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia
    Ronit Gurion
    Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski Street, Petah Tikva, Israel, 49100
    Cochrane Database Syst Rev 9:CD008238. 2011
    ..However, their safety with regard to disease-related outcomes and survival in AML is unclear. Therefore, we performed a systematic review and meta-analysis to evaluate the impact of CSFs on patient outcomes, including survival...
  13. doi request reprint High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Am J Hematol 86:657-62. 2011
    ..Extended follow up is needed to evaluate if the superior CCyR and MMolR with higher doses of imatinib will translate to long-term clinical benefit...
  14. doi request reprint Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis
    Ron Ram
    Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Cancer 116:3447-57. 2010
    ..The objective of this study was to compare the various potential therapeutic options for patients who achieved first complete remission...
  15. ncbi request reprint Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
    Mical Paul
    Department of Medicine E, Rabin Medical Center, Beilinson Campus, 49100 Petah Tiqva
    J Antimicrob Chemother 55:436-44. 2005
    ..To assess the value of empirical anti-Gram-positive antibiotics for the treatment of febrile neutropenia...
  16. doi request reprint The role of (18)F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Electronic address
    Leuk Res 37:1057-62. 2013
    ..PET/CT was beneficial in diagnosing abdominal infections. PET/CT has a potential role in the diagnostic evaluation of patients with persistent febrile neutropenia. ..
  17. pmc Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis
    Ronit Gurion
    Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Haematologica 94:712-9. 2009
    ..Therefore, it should not be recommended routinely as an adjunct to the immunosuppressive therapy for patients with aplastic anemia...
  18. pmc Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials
    Luisa Bonilla
    Institute of Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel
    J Natl Cancer Inst 102:1845-54. 2010
    ..We performed a systematic review and meta-analysis of the existing data from randomized controlled trials regarding the efficacy and toxicity of the dose-dense chemotherapy approach in nonmetastatic breast cancer...
  19. pmc 5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome--a systematic review and meta-analysis
    Ronit Gurion
    Institute of Hematology, Davidoff Cancer Center Beilinson Hospital, Rabin Medical Center, Petah Tikva 49100, Israel
    Haematologica 95:303-10. 2010
    ..Further studies are needed to establish the exact role of decitabine compared to 5-azacitidine in these patients...
  20. doi request reprint Aminoglycoside drugs in clinical practice: an evidence-based approach
    Leonard Leibovici
    Department of Medicine E, Beilinson Campus, Petah Tiqva 49100, Israel
    J Antimicrob Chemother 63:246-51. 2009
    ..They probably induce less resistance. Pragmatic large trials are needed to answer open clinical questions on the use of aminoglycosides...
  21. doi request reprint The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission
    Eli Muchtar
    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski Street, Petah Tikva, Israel, 49100
    Cochrane Database Syst Rev 3:CD009594. 2013
    ..A consensus exists regarding the need for administration of both induction and consolidation treatments, albeit using different approaches. However, there is conflicting evidence for the role of maintenance treatment in APL patients...
  22. doi request reprint Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel net
    Acta Oncol 52:18-29. 2013
    ..Current guidelines are inconclusive regarding intravenous (IV) iron for treatment of chemotherapy-induced anaemia (CIA)...
  23. doi request reprint Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study
    Drorit Merkel
    Division of Hematology, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Israel
    Am J Hematol 88:130-4. 2013
    ..Patients with poor cytogenetics in whom AZA is prescribed despite low PLT count are particularly at high risk for infections and infection prophylaxis may be considered...
  24. doi request reprint Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
    Noa Eliakim-Raz
    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Cochrane Database Syst Rev 9:CD004418. 2012
    ..To date, no sufficient evidence exists to support this broad coverage, while limiting coverage is bound to reduce toxicity, resistance and expense...
  25. doi request reprint Anthracycline-containing regimens for treatment of follicular lymphoma in adults
    Gilad Itchaki
    Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski Street, Petah Tikva, Israel, 49100
    Cochrane Database Syst Rev 7:CD008909. 2013
    ..However, there is no proof that they are superior to non-anthracycline-containing regimens (non-ACR)...
  26. pmc The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review
    Limor Amit
    Institute of Oncology, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    PLoS ONE 8:e51780. 2013
    ..To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patients with metastatic solid tumors...
  27. doi request reprint Treatment of invasive candidal infections: systematic review and meta-analysis
    Anat Gafter-Gvili
    Department of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, 49100 Petah Tiqva, Israel
    Mayo Clin Proc 83:1011-21. 2008
    ..To compare available antifungal treatments for invasive candidiasis, a leading cause of nosocomial bloodstream infections...
  28. pmc Bisphosphonates in the adjuvant setting of breast cancer therapy-effect on survival: a systematic review and meta-analysis
    Irit Ben-Aharon
    Institute of Oncology, Davidoff Center, Rabin Medical Center, Petah Tiqva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    PLoS ONE 8:e70044. 2013
    ..The role of bisphosphonates (BP) in early breast cancer (BC) has been considered controversial. We performed a meta-analysis of all randomized controlled trials (RCTs) that appraised the effects of BP on survival in early BC...
  29. doi request reprint Burkitt's Lymphoma of the Ovary: Case Report and Review of the Literature
    Adi Shacham-Abulafia
    Institute of Hematology, Davidoff Center, Rabin Medical Center Beilinson Hospital, Petah Tikva, Israel
    Acta Haematol 129:169-74. 2013
    ..Characteristics predictive for the diagnosis of Burkitt's lymphoma were: younger age, bilateral ovarian involvement, a rapidly progressive course and high LDH levels...
  30. pmc Systematic comparison of four sources of drug information regarding adjustment of dose for renal function
    Liat Vidal
    Department of Medicine E, Beilinson Campus, Rabin Medical Center, Petah Tiqva, Israel
    BMJ 331:263. 2005
    ..To compare advice on dosage adjustment for renal impairment provided by four commonly used secondary pharmacotherapeutic sources...
  31. ncbi request reprint Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials
    Liat Vidal
    Department of Medicine E, Beilinson Campus, Rabin Medical Center, Petah Tiqva 49100
    J Antimicrob Chemother 54:29-37. 2004
    ..Oral therapy could be an alternative approach for selected patients...
  32. ncbi request reprint Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials
    Hefziba Green
    Unit of Infectious Diseases, Rabin Medical Centre, Beilison Hospital, Petah Tikva 49100, Israel
    Mayo Clin Proc 82:1052-9. 2007
    ..To assess the efficacy of prophylaxis for Pneumocystis pneumonia (PCP), caused by Pneumocystis jirovecii (formerly Pneumocystis carinii), for immunocompromised non-HIV-infected patients by conducting a systematic review and meta-analysis...